NLS Business

Finding out if you have cancer, through a simple test and even prior to any symptoms, would mean a more curative treatment and a much better prognosis of survival. Sweden has a few solutions with great potential well on their way. Swedish Elypta, founded in 2017, has made headlines and received several awards for their […]

Finland has become a hub for medical R&D, with many startups, established companies, and steps being taken to improve access to capital and provide business development expertise. While Finland has a long history of innovation, it was not until the early 2000s that healthcare and biotech began to attract significant venture capital (VC) investment. In […]

Just ten years ago it was hard to predict the progress that has been made within the field of cancer therapy. A cancer vaccine, including a universal cancer vaccine, as the ultimate goal is for many the holy grail, and several Norwegian companies are paving the way. Cancer accounted for nearly ten million deaths in […]

The United Kingdom’s decision to leave the European Union sent shockwaves across industries, including the life sciences sector. Many companies are grappling with uncertainty and are still struggling to understand the potential implications of Brexit on their operations. Despite this, some opportunities may arise, particularly for the Nordic region, which has close links with the […]

After many years of technical challenges and disappointing results, gene therapy is starting to gain real ground and holds promise within several diseases, ranging from blindness to cancer.

The global pharma company has announced an investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival. This includes new or expanded projects in Brazil, India, Vietnam, Ghana and Rwanda that will contribute to the company’s climate action, restore nature, promote biodiversity and […]